--- title: "3 Dividend Stocks Raising Their Payouts as Investors Search for Growth and Income" type: "News" locale: "en" url: "https://longbridge.com/en/news/296780069.md" description: "Omega Healthcare, Clorox, and Ashland have raised dividends, offering investors a mix of income and growth. Omega provides high yield driven by aging demographics; Clorox offers stability as a Dividend Aristocrat with 25+ years of increases; Ashland combines dividend growth with upside potential despite recent operational disruptions." datetime: "2026-08-24T11:25:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296780069.md) - [en](https://longbridge.com/en/news/296780069.md) - [zh-HK](https://longbridge.com/zh-HK/news/296780069.md) generator: "portal-rs" --- # 3 Dividend Stocks Raising Their Payouts as Investors Search for Growth and Income ## Key Points - Omega Healthcare Investors, Clorox and Ashland offer investors different combinations of dividend income and potential share-price growth. - Each company has recently increased its payout despite operating in very different industries and market environments. - Yield, dividend-growth history and company-specific catalysts can help investors distinguish among these three income opportunities. It's hard to be an investor in 2026 without a sound strategy. For growth investors, artificial intelligence (AI) stocks are still a good option. But many of these names carry more volatility than risk-averse investors would like to take on. Income-oriented investors often turn to fixed-income investments. But what these investments provide in stability, they come at the expense of growth. That's why many investors are turning to quality dividend stocks. These investments can provide a solid mix of growth and income, increasing an investor's total return. And when companies increase their dividend, it creates a compounding effect that, over time, can lead to gains that exceed those of many growth stocks. Many companies use earnings season as an opportunity to announce dividend increases. But before looking at each stock, it's important to explain why all dividend stocks aren't alike. ## Dividend Growth Matters More Than a High Yield In many cases, dividend analysis starts with a stock's dividend yield. Conventional wisdom holds that the higher the yield, the better the dividend. That's not a bad premise, but it's not the whole story. In fact, in some cases, the yield can mask a company's underlying problems. A better indicator of dividend quality is when a company increases its payout. The dividend is frequently paid out of earnings. So when a company increases its dividend payout, it's making a statement about the stability and likely growth of future earnings. That can create a virtuous cycle in which earnings growth fuels dividend growth, which fuels stock price growth. That combination of growth and income builds on itself year after year. One way to identify dividend raisers likely to increase their payouts is to look for stocks with current or future catalysts. Here are three stocks that have increased their dividends and the catalysts likely to drive further dividend growth. ## Omega Healthcare Stock Offers High Yield and Dividend Growth Omega Healthcare (NYSE: OHI) is an example of a dividend stock that offers both a high yield and an opportunity for solid future growth. The real estate investment trust (REIT) is the largest pure-play skilled-nursing landlord in the country. That positioning plays well as the aging-of-America narrative, pitched 20 years ago, is now a reality. Over the last 20 years, OHI has delivered a total return of over 1,200%. That's due in no small part to the company's dividend. REITs have tax advantages that require them to pay out a high percentage of their earnings as dividends. That doesn't necessarily mean the company will increase its dividend. But Omega recently did just that as tenant coverage rates recover. At 68 cents per share and with a dividend yield of 5.79%, OHI is worth a look, particularly for investors who believe the payout will continue to increase. ## Clorox Stock Shows the Power of Dividend Aristocrat Status When it comes to slow and steady compounding, The Clorox Company (NYSE: CLX) shows why it can be a core holding in a dividend portfolio. Consumer staples stocks have been brutal for growth investors as inflation and higher interest rates drive shifts toward private-label brands. Clorox has not been immune. The company was a superstar during the pandemic, but has come through harder times since then. Still, CLX has delivered a total return of over 220% over the last 20 years, and the dividend is a key reason. Despite the ups and downs, Clorox has continued to increase its dividend. In fact, the company is part of an exclusive group of stocks known as Dividend Aristocrats that have increased their payout for at least 25 consecutive years. Investors also get a yield of 4.62%, which is well above the sector average. ## Ashland Stock Combines Dividend Growth With Upside Potential Ashland Inc. (NYSE: ASH) is a materials company that focuses on specialty chemicals. ASH is up over 34% in the last 12 months, with most of that gain coming in 2026. That growth comes despite material internal manufacturing disruptions at the company's Hopewell facility and the Calvert City outage However, analysts have been raising their price targets above the current consensus price of $73.90. The nature of the company's business is cyclical. That hasn't kept the company from increasing its dividend for 16 consecutive years. That growth has come at an annual growth rate of 8.3% over the last five years. That dividend currently yields 2.32%, but the stock has had a total return similar to Clorox over the last 20 years. That's a dynamic that investors can get behind. Get Income-Generating Stocks Like Omega Healthcare Investors in Your Inbox. Stop riding the roller coaster of the stock market and sign-up to receive DividendStocks.com's daily ex-dividend stocks and dividend investing news for OHI and related companies. ## Companies Mentioned in This Article: | Company | Current Price | Price Change | Dividend Yield | P/E Ratio | Consensus Rating | Consensus Price Target | | ------------- | ------------- | ------------ | -------------- | --------- | ---------------- | ---------------------- | | Clorox (CLX) | $107.00 | +0.3% | 4.67% | 22.20 | Reduce | $102.40 | | Ashland (ASH) | $72.97 | +0.4% | 2.30% | 64.01 | Moderate Buy | $73.90 | ## About Chris Markoch \[email protected\] ### Experience Chris Markoch has been an associate editor & contributing author for DividendStocks.com since 2018. - **Professional Background:** Christopher Markoch is a freelance writer and market analyst with over 30 years of experience in marketing communications, including work with financial services firms and banks. His unique blend of communication expertise and market knowledge allows him to break down complex financial topics for individual investors. - **Credentials:** He holds a Bachelor of Arts in Business and Organizational Communication from The University of Akron in Akron, Ohio. - **Finance Experience:** Chris has been an editor and contributing writer for DividendStocks.com since 2018 and has also written for InvestorPlace. He began writing about finance and investing in 2017, bringing a strong focus on helping readers make confident, informed decisions. - **Writing Focus:** He specializes in value investing, dividend-paying stocks, and retirement-focused strategies. His work is geared toward individual investors looking to build stable, income-generating portfolios. - **Investment Approach:** Chris emphasizes value and income investing while maintaining a focus on context and clarity. He believes that fundamentals and technicals are important, but they only become truly useful when paired with an understanding of a company’s story. That perspective shapes both his investing decisions and the guidance he offers to readers. - **Inspiration:** “The story behind a company or stock is important to me,” Chris says. “The fundamentals or technical action are interesting, but without the why, they lack context for retail investors. That’s what I aim to deliver.” - **Fun Fact:** Christopher admires thought leaders like Keith Fitz-Gerald and Shah Gilani for their sharp market insight. - **Areas of Expertise:** Value investing, retirement stocks, dividend stocks, individual investing ### Education Bachelor of Arts in Business and Organizational Communication, The University of Akron, Akron, Ohio ### Past Experience InvestorPlace ### Related Stocks - [ASH.US](https://longbridge.com/en/quote/ASH.US.md) - [CLX.US](https://longbridge.com/en/quote/CLX.US.md) - [OHI.US](https://longbridge.com/en/quote/OHI.US.md) ## Related News & Research - [Clorox (CLX) Stock Looks Fully Valued Despite A 23% Five Year Slide](https://longbridge.com/en/news/296685126.md) - [Mega IPOs Could be Coming: Here’s How They Might Impact Dividends](https://longbridge.com/en/news/296815476.md) - [Permian Basin Royalty Trust declares $0.0187 dividend](https://longbridge.com/en/news/296740052.md) - [PermRock Royalty Trust declares $0.0218 dividend](https://longbridge.com/en/news/296740058.md) - [Cross Timbers Royalty Trust declares $0.0679 dividend](https://longbridge.com/en/news/296735615.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**